In-licensing

As renowned leaders in commercialising value-added medicines in the UK and across Europe, we have a deep understanding of European healthcare systems and how to navigate the complexities involved in achieving commercial success.

Our team’s expertise in the sales and marketing of products and our track record of achieving marketing authorisation and overcoming pricing and reimbursement challenges with strategic knowledge, is why we have been able to establish ourselves as renowned leaders in repurposing medicines in the UK and across Europe.

Guiding your medicine's journey

Bringing value-added medicines to the UK and our European platform involves pivotal steps from regulatory approval, to developing pricing strategies, local formulary engagement, and more.

No matter your position in the product lifecycle, whether you are seeking regulatory approval, possess a dossier, or hold a marketing authorisation, we will work with you to streamline the steps to commercialisation.

Regulatory approval

We have a strong understanding of what it takes for a product to receive regulatory approval in the UK and across European healthcare systems, and have successfully achieved marketing authorisation for multiple products in various countries.

Pricing and reimbursement

Our expertise lies in navigating the complexity of various reimbursement mechanisms. Leveraging our in-depth understanding of the UK drug tariff and those across Europe, we’re able to develop appropriate pricing strategies across different reimbursement channels, which in turn enables us to drive more value for our partners.

Market access and commercialisation

What sets Colonis apart is our expertise to successfully navigate and commercialise a product beyond regulatory approvals.

Each in-licensed product requires a tailored market access strategy that involves adaptable commercial expertise.

Our expert analysis of the current marketplace enables us to maximise commercial opportunities to ensure value-added medicines are available to healthcare professionals and reach patients. This involves securing patient pathways, formulary listings, and guideline inclusions, orchestrating marketing and sales efforts, efficient supply chain management, and engaging with healthcare providers, professionals, and patient advocacy groups.

Our success, your growth

With a track record of commercial success, by nurturing our business, we inherently contribute to yours.

If you are looking to:

Achieve marketing authorisation in the UK and across our European platform

Establish the right price for your product

Establish a long-term partnership

Work with a team experienced in commercialising medicines across the UK and EU

We'd love to hear from you

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being redirected to a Clinigen Group website.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the Clinigen website.

You are now leaving

You are now leaving the Colonis website and being directed to an external website for which Colonis is not responsible.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the external website.

You are now leaving

You are now leaving the Colonis website and being directed to an external website for which Colonis is not responsible.

Click “Cancel” to remain on the Colonis website.
Click “Continue” to visit the external website.